Mapping the material financial risks that sink hospitals

# Mapping the material financial risks that sink hospitals

In 2019, Philadelphia's Hahnemann University Hospital closed after roughly 170 years of operation. The trigger was not a medical failure. It was cash. Thin margins, heavy debt, and a payer mix that could not cover fixed costs. When a 500-bed academic hospital vanishes in months, the lesson is blunt: hospitals do not usually die from bad medicine. They die from bad finance.

This lesson maps the four financial risks that most reliably push hospitals toward distress, with the numbers you need to size each one.

Why hospital finance is fragile by design

Hospitals carry high fixed costs (staff, buildings, equipment) and collect revenue from third parties, not patients directly. That collection is slow, contested, and regulated.

The single most important concept: hospitals rarely get paid what they bill. Gross charges are a fiction. Actual collections depend on payers, denials, and policy.

Two US terms to fix now:

• Payer: whoever pays the bill. In the US: Medicare (federal, age 65+ and disabled), Medicaid (state and federal, low-income), and commercial insurers (Aetna, UnitedHealthcare, etc.).
• Payer mix: the share of revenue from each. A hospital heavy on Medicaid and self-pay is structurally weaker, because those pay less than commercial plans.

Operating margins are thin. US hospital median operating margins have hovered in the low single digits in recent years (widely cited industry estimates around 1 to 4 percent, as of 2024 to 2025 reporting). At that thinness, a small revenue shock is existential.

Risk 1: Payer denial rates

A denial is when a payer refuses to pay a submitted claim, fully or partially. Reasons: missing prior authorization, coding errors, "not medically necessary," or eligibility problems.

Denials are the slow bleed. Industry surveys (KFF and provider association estimates, 2023 to 2024) put initial denial rates in the range of roughly 10 to 15 percent of claims for many hospitals, with some Medicare Advantage plans higher. Even when appealed successfully, the delay ties up cash.

Why it hits finance, not just admin

Every denied claim consumes staff time to rework, delays cash, and a chunk is never recovered. That permanently lost revenue is called leakage.

Worked example:

• Hospital submits $500 million in net expected claims per year.
• Initial denial rate: 12 percent, so $60 million denied initially.
• Say 65 percent is overturned on appeal, so about $39 million recovered.
• Unrecovered: roughly $21 million, plus appeal labor costs.

On a 3 percent margin, $21 million of leakage can wipe out a large share of annual profit at a mid-size system.

Due-diligence check: Ask for the initial denial rate, the final denial rate (after appeals), and the trend over 8 quarters. A rising trend is a red flag, often signaling a payer contract dispute or worsening documentation.

Risk 2: Bad-debt escalation

Bad debt is revenue the hospital expected to collect but wrote off as uncollectible, usually the patient's own portion (deductibles, copays, uninsured balances).

This risk has grown with high-deductible health plans (HDHPs), insurance where patients pay large amounts out of pocket before coverage kicks in. When a patient owes $4,000 before insurance pays, collection rates fall sharply.

Do not confuse bad debt with charity care (care the hospital deliberately provides free to qualifying patients). Both reduce cash, but they are accounted for differently and scrutinized differently by regulators.

The check that matters

Look at days in accounts receivable (AR days): how many days of revenue are sitting uncollected.

Worked example:

• Net patient revenue: $500 million per year, so about $1.37 million per day.
• Accounts receivable balance: $75 million.
• AR days = 75 / 1.37 ≈ 55 days.

US hospitals commonly target something in the region of 40 to 55 AR days (operational benchmark, varies by system). Rising AR days plus rising bad-debt write-offs together mean the hospital is booking revenue it will never see.

For US nonprofit hospitals, note that IRS Section 501(r) (Affordable Care Act) requires written financial assistance policies and limits aggressive collections. Weak compliance here is both a financial and a regulatory risk.

Risk 3: RAC and payer clawbacks

This is the one outsiders underestimate. A clawback is money a payer takes back after already paying, on the grounds the claim should not have been paid.

The formal US mechanism is the Recovery Audit Contractor (RAC) program, run by the Centers for Medicare and Medicaid Services (CMS), the federal agency overseeing Medicare and Medicaid. RACs are private auditors paid on contingency: they earn a percentage of what they recover, which sharply incentivizes them to find overpayments.

The classic target: short-stay inpatient admissions that auditors reclassify as outpatient "observation," which pays less. The care happened. The payment gets reversed.

CMS publishes RAC program results here: CMS Recovery Audit Program.

Why it is a distress trigger

Clawbacks hit past periods. A hospital can book a profitable year, then face a multimillion-dollar recoupment demand that turns it into a loss. Commercial payers run their own audit clawbacks too, often more aggressive than Medicare.

Due-diligence check: Ask for the contractual allowance and audit reserve on the balance sheet, and the history of recoupments over 3 years. A hospital with no reserve for future clawbacks is understating risk. Ask specifically about open RAC and payer audits and estimated exposure.

Risk 4: Reimbursement policy shifts

The prior three risks are about collecting what you are owed. This one is about the rules changing on how much you are owed.

Reimbursement is simply how much a payer pays per service. In the US, government reimbursement is set by policy, not negotiation, and it can move with a single ruling.

Key mechanisms to know:

• Medicare fee schedules and DRGs. A DRG (Diagnosis Related Group) is a fixed payment for a category of hospitalization. CMS updates these annually. A rate change flows straight to the bottom line.
• 340B Drug Pricing Program. This lets qualifying safety-net hospitals buy outpatient drugs at a discount and keep the spread. Policy fights over 340B (litigated repeatedly through the early 2020s) directly threaten a major profit source for many US hospitals.
• Medicaid expansion and state budgets. In non-expansion states, hospitals carry more uninsured patients, worsening bad debt (see Risk 2). Medicaid is state-administered, so cuts can arrive fast.

Europe contrast

In much of Europe, hospitals are funded through national or regional budgets and tariff systems. Germany uses a DRG-based system (G-DRG); England's NHS uses a national tariff (the NHS Payment Scheme). The risk profile differs: less claim-denial warfare, but heavy exposure to government budget decisions and tariff freezes. When a national tariff fails to keep pace with inflation, every hospital in the system is squeezed at once (a documented pressure across NHS providers in recent years, per public NHS financial reporting).

The check

Model payer concentration and policy sensitivity.